BRTX vs CLOV
BioRestorative Therapies Inc (BRTX) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BRTX currently screens at market cap $10.2M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BRTX and CLOV stock pages for the full models.
Not investment advice.